The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019
Open accessAbstract
Background Emerging evidence shows that severe coronavirus disease 2019 (COVID-19) can be complicated by a significant coagulopathy, that likely manifests in the form of both microthrombosis and VTE. This recognition has led to the urgent need for practical guidance regarding prevention, diagnosis, and treatment of VTE. Methods A group of approved panelists developed key clinical questions by using the PICO (Population, Intervention, Comparator, Outcome) format that addressed urgent clinical questions regarding the prevention, diagnosis, and treatment of VTE in patients with COVID-19. MEDLINE (via PubMed or Ovid), Embase, and Cochrane Controlled Register of Trials were systematically searched for relevant literature, and references were screened for inclusion. Validated evaluation tools were used to grade the level of evidence to support each recommendation. When evidence did not exist, guidance was developed based on consensus using the modified Delphi process. Results The systematic review and critical analysis of the literature based on 13 Population, Intervention, Comparator, Outcome questions resulted in 22 statements. Very little evidence exists in the COVID-19 population. The panel thus used expert consensus and existing evidence-based guidelines to craft the guidance statements. Conclusions The evidence on the optimal strategies to prevent, diagnose, and treat VTE in patients with COVID-19 is sparse but rapidly evolving.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Tang, N., Li, D., Wang, X., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14768 · Cited by 5,662
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
Klok, F. A., Kruip, M. J. H. A., van der Meer, N. J. M., Arbous, M. S., Gommers, D. A. M. P. J., Kant, K. M., Kaptein, F. H. J., van Paassen, J., Stals, M. A. M., Huisman, M. V., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.013 · Cited by 5,028
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz405 · Cited by 4,916
Self-citationAntithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
Self-citationTang, N., Bai, H., Chen, X., Gong, J., Li, D., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14817 · Cited by 3,559
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007903 · Cited by 3,237
Bikdeli, B., Madhavan, M. V., Jimenez, D., Chuich, T., Dreyfus, I., Driggin, E., Nigoghossian, C. D., Ageno, W., Madjid, M., Guo, Y., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.031 · Cited by 2,885
Self-citationCRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis), Helms, J., Tacquard, C., Severac, F., Leonard-Lorant, I., Ohana, M., Delabranche, X., Merdji, H., Clere-Jehl, R., Schenck, M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06062-x · Cited by 2,792
Kahn (2012) · doi:10.1378/chest.11-2296 · Cited by 2,693
Büller (2012) · doi:10.1056/nejmoa1113572 · Cited by 2,353
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
Agnelli, G., Buller, H. R., Cohen, A., Curto, M., Gallus, A. S., Johnson, M., Masiukiewicz, U., Pak, R., Thompson, J., Raskob, G. E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302507 · Cited by 2,324
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study
Wichmann, D., Sperhake, J.-P., Lütgehetmann, M., Steurer, S., Edler, C., Heinemann, A., Heinrich, F., Mushumba, H., Kniep, I., Schröder, A. S., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2003 · Cited by 2,274
Lodigiani, C., Iapichino, G., Carenzo, L., Cecconi, M., Ferrazzi, P., Sebastian, T., Kucher, N., Studt, J.-D., Sacco, C., Bertuzzi, A., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.024 · Cited by 2,054
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M., Clark, C., & Iba, T. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14810 · Cited by 1,925
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
The Hokusai-VTE Investigators (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306638 · Cited by 1,869
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Cui, S., Chen, S., Li, X., Liu, S., & Wang, F. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14830 · Cited by 1,806
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01647-2019 · Cited by 1,619
Klok, F. A., Kruip, M. J. H. A., van der Meer, N. J. M., Arbous, M. S., Gommers, D., Kant, K. M., Kaptein, F. H. J., van Paassen, J., Stals, M. A. M., Huisman, M. V., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.041 · Cited by 1,601
Samama, M. M., Cohen, A. T., Darmon, J.-Y., Desjardins, L., Eldor, A., Janbon, C., Leizorovicz, A., Nguyen, H., Olsson, C.-G., Turpie, A. G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411103 · Cited by 1,584
Incidence of venous thromboembolism in hospitalized patients with COVID‐19
Middeldorp, S., Coppens, M., van Haaps, T. F., Foppen, M., Vlaar, A. P., Müller, M. C. A., Bouman, C. C. S., Beenen, L. F. M., Kootte, R. S., Heijmans, J., et al. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14888 · Cited by 1,447
BARBAR, S., NOVENTA, F., ROSSETTO, V., FERRARI, A., BRANDOLIN, B., PERLATI, M., DE BON, E., TORMENE, D., PAGNAN, A., & PRANDONI, P. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04044.x · Cited by 1,240
High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients
Llitjos, J., Leclerc, M., Chochois, C., Monsallier, J., Ramakers, M., Auvray, M., & Merouani, K. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14869 · Cited by 1,206
Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence
Poissy, J., Goutay, J., Caplan, M., Parmentier, E., Duburcq, T., Lassalle, F., Jeanpierre, E., Rauch, A., Labreuche, J., Susen, S., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.047430 · Cited by 1,071
Heparin and Low-Molecular-Weight Heparin
Hirsh, J., Warkentin, T. E., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (1998) · Chest · doi:10.1378/chest.114.5_supplement.489s · Cited by 1,031
Cardiovascular complications in COVID-19
Long, B., Brady, W. J., Koyfman, A., & Gottlieb, M. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.04.048 · Cited by 974
Heparin and Low-Molecular-Weight Heparin
Hirsh, J., & Raschke, R. (2004) · Chest · doi:10.1378/chest.126.3_suppl.188s · Cited by 971
The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome
Ranucci, M., Ballotta, A., Di Dedda, U., Baryshnikova, E., Dei Poli, M., Resta, M., Falco, M., Albano, G., & Menicanti, L. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14854 · Cited by 965
Leizorovicz, A., Cohen, A. T., Turpie, A. G. G., Olsson, C.-G., Vaitkus, P. T., & Goldhaber, S. Z. (2004) · Circulation · doi:10.1161/01.cir.0000138928.83266.24 · Cited by 955
Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies
Tian, S., Xiong, Y., Liu, H., Niu, L., Guo, J., Liao, M., & Xiao, S.-Y. (2020) · Modern Pathology · doi:10.1038/s41379-020-0536-x · Cited by 948
Paranjpe, I., Fuster, V., Lala, A., Russak, A. J., Glicksberg, B. S., Levin, M. A., Charney, A. W., Narula, J., Fayad, Z. A., Bagiella, E., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.001 · Cited by 920
Cohen, A. T., Davidson, B. L., Gallus, A. S., Lassen, M. R., Prins, M. H., Tomkowski, W., Turpie, A. G. G., Egberts, J. F. M., & Lensing, A. W. A. (2006) · BMJ · doi:10.1136/bmj.38733.466748.7c · Cited by 857
Schünemann, H. J., Cushman, M., Burnett, A. E., Kahn, S. R., Beyer-Westendorf, J., Spencer, F. A., Rezende, S. M., Zakai, N. A., Bauer, K. A., Dentali, F., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018022954 · Cited by 819
Spiezia, L., Boscolo, A., Poletto, F., Cerruti, L., Tiberio, I., Campello, E., Navalesi, P., & Simioni, P. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1710018 · Cited by 699
Predictive and Associative Models to Identify Hospitalized Medical Patients at Risk for VTE
Spyropoulos, A. C., Anderson, F. A., FitzGerald, G., Decousus, H., Pini, M., Chong, B. H., Zotz, R. B., Bergmann, J.-F., Tapson, V., Froehlich, J. B., et al. (2011) · Chest · doi:10.1378/chest.10-1944 · Cited by 550
Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation
Iba, T., Levy, J. H., Warkentin, T. E., Thachil, J., van der Poll, T., & Levi, M. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14578 · Cited by 531
Barnes, G. D., Burnett, A., Allen, A., Blumenstein, M., Clark, N. P., Cuker, A., Dager, W. E., Deitelzweig, S. B., Ellsworth, S., Garcia, D., et al. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02138-z · Cited by 467
Dalteparin versus Unfractionated Heparin in Critically Ill Patients
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014475 · Cited by 459
Severe COVID-19 infection associated with endothelial activation
Escher, R., Breakey, N., & Lämmle, B. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.014 · Cited by 441
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19
Wang, T., Chen, R., Liu, C., Liang, W., Guan, W., Tang, R., Tang, C., Zhang, N., Zhong, N., & Li, S. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30109-5 · Cited by 376
Zhai, Z., Li, C., Chen, Y., Gerotziafas, G., Zhang, Z., Wan, J., Liu, P., Elalamy, I., Wang, C., & On behalf of the Prevention Treatment of VTE Associated with COVID-19 Infection Consensus Statement Group (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1710019 · Cited by 365
Marietta, M., Ageno, W., Artoni, A., Candia, E. D., Gresele, P., Marchetti, M., Marcucci, R., & Tripodi, A. (2020) · Blood transfusion · doi:10.2450/2020.0083-20 · Cited by 348
Oudkerk, M., Büller, H. R., Kuijpers, D., van Es, N., Oudkerk, S. F., McLoud, T., Gommers, D., van Dissel, J., ten Cate, H., & van Beek, E. J. R. (2020) · Radiology · doi:10.1148/radiol.2020201629 · Cited by 343
Nadroparin in the Prevention of Deep Vein Thrombosis in Acute Decompensated COPD
FRAISSE, F., HOLZAPFEL, L., COULAND, J.-M., SIMONNEAU, G., BEDOCK, B., FEISSEL, M., HERBECQ, P., PORDES, R., POUSSEL, J.-F., ROUX, L., et al. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.9807025 · Cited by 300
Disseminated intravascular coagulation in patients with 2019‐nCoV pneumonia
Lillicrap, D. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14781 · Cited by 299
VTE Incidence and Risk Factors in Patients With Severe Sepsis and Septic Shock
Kaplan, D., Casper, T. C., Elliott, C. G., Men, S., Pendleton, R. C., Kraiss, L. W., Weyrich, A. S., Grissom, C. K., Zimmerman, G. A., & Rondina, M. T. (2015) · Chest · doi:10.1378/chest.15-0287 · Cited by 271
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness
Spyropoulos, A. C., Ageno, W., Albers, G. W., Elliott, C. G., Halperin, J. L., Hiatt, W. R., Maynard, G. A., Steg, P. G., Weitz, J. I., Suh, E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805090 · Cited by 248
Smythe, M. A., Priziola, J., Dobesh, P. P., Wirth, D., Cuker, A., & Wittkowsky, A. K. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1315-2 · Cited by 231
CARRIER, M., LE GAL, G., CHO, R., TIERNEY, S., RODGER, M., & LEE, A. Y. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03326.x · Cited by 229
Self-citationAdjunctive intermittent pneumatic compression for venous thromboprophylaxis.
Arabi, Y. M., Al-Hameed, F., Burns, K. E. A., Mehta, S., Alsolamy, S. J., Alshahrani, M. S., Mandourah, Y., Almekhlafi, G. A., Almaani, M., Al Bshabshe, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1816150 · Cited by 215
Rosenberg, D., Eichorn, A. M., Alarcon, M., McCullagh, L., McGinn, T. G., & Spyropoulos, A. C. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001152 · Cited by 183
Thomas, W., Varley, J., Johnston, A., Symington, E., Robinson, M., Sheares, K., Lavinio, A., & Besser, M. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.028 · Cited by 178
Testa, S., Prandoni, P., Paoletti, O., Morandini, R., Tala, M., Dellanoce, C., Giorgi‐Pierfranceschi, M., Betti, M., Danzi, G. B., Pan, A., et al. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14871 · Cited by 169
Alhazzani, W., Lim, W., Jaeschke, R. Z., Murad, M. H., Cade, J., & Cook, D. J. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31828cf104 · Cited by 168
Gibson, C. M., Spyropoulos, A. C., Cohen, A. T., Hull, R. D., Goldhaber, S. Z., Yusen, R. D., Hernandez, A. F., Korjian, S., Daaboul, Y., Gold, A., et al. (2017) · TH Open · doi:10.1055/s-0037-1603929 · Cited by 159
Spyropoulos, A. C., Lipardi, C., Xu, J., Peluso, C., Spiro, T. E., Sanctis, Y. D., Barnathan, E. S., & Raskob, G. E. (2020) · TH Open · doi:10.1055/s-0040-1705137 · Cited by 154
Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patients
Amin, A., Varker, H., Princic, N., Lin, J., Thompson, S., & Johnston, S. S. (2011) · Journal of Hospital Medicine · doi:10.1002/jhm.1002 · Cited by 152
Darzi, A., Karam, S. G., Charide, R., Etxeandia‐Ikobaltzeta, I., Cushman, M., Gould, M. K., Mbuagbaw, L. C. E., Spencer, F. A., Spyropoulos, A. C., Streiff, M. B., et al. (2020) · Blood · doi:10.1182/blood.2019003603 · Cited by 139
Evidence vs Consensus in Clinical Practice Guidelines
Djulbegović, B., & Guyatt, G. H. (2019) · JAMA · doi:10.1001/jama.2019.9751 · Cited by 137
Covid-19 — A Reminder to Reason
Zagury‐Orly, I., & Schwartzstein, R. M. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2009405 · Cited by 128
Vivas, D., Roldán, V., Esteve‐Pastor, M. A., Roldán, I., Tello‐Montoliu, A., Ruiz-Nodar, J. M., Cosín-Sales, J., Martínez, J. M. G., Consuegra, L., Ferreiro, J. L., et al. (2020) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.04.006 · Cited by 118
Validation of Risk Assessment Models of Venous Thromboembolism in Hospitalized Medical Patients
Greene, M. T., Spyropoulos, A. C., Chopra, V., Grant, P., Kaatz, S., Bernstein, S. J., & Flanders, S. A. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.03.031 · Cited by 116
Schulman, S., Zondag, M., Linkins, L., Pasca, S., Cheung, Y. W., de Sancho, M., Gallus, A. S., Lecumberri, R., Molnar, S., Ageno, W., et al. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12955 · Cited by 113
Casini, A., Alberio, L., Angelillo‐Scherrer, A., Fontana, P., Gerber, B., Graf, L., Hegemann, I., Korte, W. C., Hovinga, J. A. K., Lecompte, T., et al. (2020) · Swiss Medical Weekly · doi:10.4414/smw.2020.20247 · Cited by 100
Vivas, D., Roldán, V., Esteve‐Pastor, M. A., Roldán, I., Tello‐Montoliu, A., Ruiz-Nodar, J. M., Cosín-Sales, J., Martínez, J. M. G., Consuegra, L., Ferreiro, J. L., et al. (2020) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2020.04.025 · Cited by 97
Vardi, M., Ghanem‐Zoubi, N., Zidan, R. A., Yurin, V., & Bitterman, H. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12108 · Cited by 80
Luk, C., Wells, P. S., Anderson, D. R., & Kovacs, M. J. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00840-3 · Cited by 78
Self-citationVenous thromboembolism in critically ill patients: Observations from a randomized trial in sepsis
Williams, M. D., & Shorr, A. F. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-07-0468 · Cited by 77
Ihaddadene, R., Gal, G. L., Delluc, A., & Carrier, M. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.04.028 · Cited by 65
Self-citationMoumneh, T., Riou, J., Douillet, D., Henni, S., Mottier, D., Tritschler, T., Gal, G. L., & Roy, P. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14796 · Cited by 59
Self-citationBajaj, N. S., Vaduganathan, M., Qamar, A., Gupta, K., Gupta, A., Golwala, H. B., Butler, J., Goldhaber, S. Z., & Mehra, M. R. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002797 · Cited by 54
Fibrinolysis for Intermediate-Risk Pulmonary Embolism
Meyer, G., Vicaut, É., & Konstantinides, S. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1406283 · Cited by 38
Neumann, I., Izcovich, A., Zhang, Y., Gabriel Rada, G., Kahn, S. R., Spencer, F. A., Rezende, S. M., Dentali, F., Bauer, K. A., Morgano, G. P., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000840 · Cited by 36
Validation of risk assessment models for venous thrombosis in hospitalized medical patients
Cobben, M. R. R., Nemeth, B., Lijfering, W. M., & Cannegieter, S. C. (2019) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12181 · Cited by 21
Cited by
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
Berlin, D. A., Gulick, R. M., & Martinez, F. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmcp2009575 · Cited by 1,439
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Lim, S., Bae, J. H., Kwon, H.-S., & Nauck, M. A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00435-4 · Cited by 1,006
Malas, M. B., Naazie, I. N., Elsayed, N., Mathlouthi, A., Marmor, R., & Clary, B. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100639 · Cited by 685
INSPIRATION Investigators, Mazloomzadeh, S., Khaleghparast, S., Ghadrdoost, B., Mousavizadeh, M., Baay, M. R., Noohi, F., Sharifnia, H., Ahmadi, A., Tavan, S., et al. (2021) · JAMA · doi:10.1001/jama.2021.4152 · Cited by 625
Self-citation
Metadata
- Authors
- Moores, L. K., Tritschler, T., Brosnahan, S., Carrier, M., Collen, J. F., Doerschug, K., Holley, A. B., Jimenez, D., Le Gal, G., Rali, P., & Wells, P.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 158
- Issue
- 3
- Pages
- 1143-1163
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W3045413314
- Cited by
- 638
- References
- 76
- FWCI
- 74.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.